Concepedia

Björn Cochlovius

BC

12

Publications

649

Citations

12

H-Index

1998

Active since

Affiliations

German Cancer Research Center(Current)

Heidelberg University

Affimed Therapeutics (Germany)

Karlsruhe University of Applied Sciences

Recombinant Antibody Technology (United Kingdom)

Björn Cochlovius is an author at German Cancer Research Center specializing in immunology, medicine, and immunotherapy.

Top concepts

Publications per year

1998–2004

12

Publications

12

Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics

Sergey M Kipriyanov, Gerhard Moldenhauer, Jochen Schuhmacher et al. · Journal of Molecular Biology · 1999 · 194 citations

, , +10

Synergistic Antitumor Effect of Bispecific CD19 × CD3 and CD19 × CD16 Diabodies in a Preclinical Model of Non-Hodgkin’s Lymphoma

Sergey M. Kipriyanov, Björn Cochlovius, Holger Schäfer et al. · The Journal of Immunology · 2002 · 90 citations · Full text

Treatment of Human B Cell Lymphoma Xenografts with a CD3 × CD19 Diabody and T Cells

Björn Cochlovius, Sergey M. Kipriyanov, Marike Stassar et al. · The Journal of Immunology · 2000 · 78 citations · Full text

, , +21

Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas

Rudolf Schmits, Björn Cochlovius, Gerhard Treitz et al. · International Journal of Cancer · 2001 · 65 citations

Effect of Domain Order on the Activity of Bacterially Produced Bispecific Single-chain Fv Antibodies

Sergey M. Kipriyanov, Gerhard Moldenhauer, Michael Braunagel et al. · Journal of Molecular Biology · 2003 · 56 citations

, , +7

Rows per page

1–5 of 12